Pasternak Andy
Insider CIK 1792746 · HZNP EVP, Chief Strategy Officer · CNTX Director · KARD Chief Strategy Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTX Context Therapeutics Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KARD Kardigan, Inc. | A Award | 2026-06-17 | 2026-06-22 | 79,640 | — | $0 | 79,640 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2025-06-12 | 2025-06-12 | 138,900 | — | $0 | 138,900 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2025-01-13 | 2025-01-14 | 20,685 | — | $0 | 20,685 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 5,816 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 4,761 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 14,282 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 23,806 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 11,499 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 5,749 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 5,749 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 34,928 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 15,281 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 15,870 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 22,997 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 11,643 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 56,338 | $116.50 | $6.56M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2023-01-17 | 2023-01-18 | 27,129 | $113.03 | $3.07M | 56,338 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2023-01-04 | 2023-01-06 | 22,997 | — | $0 | 22,997 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 7,935 | — | $0 | 15,870 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 11,643 | — | $0 | 11,643 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 14,514 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 11,648 | — | $0 | 5,816 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 26,124 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 8,709 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 2,360 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 5,800 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-12-30 | 2023-01-04 | 88,733 | — | $0 | 122,780 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2022-12-30 | 2023-01-04 | 39,313 | $113.80 | $4.47M | 83,467 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-12-27 | 2022-12-29 | 17,464 | — | $0 | 17,464 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-12-27 | 2022-12-29 | 26,124 | — | $0 | 26,124 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-13 | 2022-12-14 | 23,251 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-12-13 | 2022-12-14 | 23,251 | $29.52 | $686.4K | 64,216 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-12-13 | 2022-12-14 | 23,251 | $112.61 | $2.62M | 40,965 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-12-13 | 2022-12-14 | 6,918 | $112.60 | $779.0K | 34,047 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-11-01 | 2022-11-02 | 12,421 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2022-11-01 | 2022-11-02 | 5,503 | $63.18 | $347.7K | 40,965 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-11-01 | 2022-11-02 | 12,421 | — | $0 | 46,468 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-07-29 | 2022-07-29 | 643 | $83.45 | $53.7K | 34,047 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-07-29 | 2022-07-29 | 4,207 | $82.44 | $346.8K | 34,690 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-06-10 | 2022-06-13 | 762 | $85.36 | $65.0K | 38,897 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-02-18 | 2022-02-18 | 1,313 | $94.82 | $124.5K | 39,659 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-01-06 | 2022-01-06 | 349 | $100.23 | $35.0K | 40,972 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-01-06 | 2022-01-06 | 700 | $98.33 | $68.8K | 47,759 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-01-06 | 2022-01-06 | 500 | $97.30 | $48.6K | 48,459 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-01-06 | 2022-01-06 | 6,438 | $99.85 | $642.8K | 41,321 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 14,514 | — | $0 | 14,514 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 11,067 | — | $0 | 11,069 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 11,616 | — | $0 | 5,800 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 11,642 | — | $0 | 23,286 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2022-01-05 | 2022-01-06 | 21,710 | $101.84 | $2.21M | 48,959 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-01-05 | 2022-01-06 | 48,839 | — | $0 | 70,669 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-01-04 | 2022-01-06 | 23,805 | — | $0 | 23,805 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-12-07 | 2021-12-08 | 1,525 | $100.00 | $152.5K | 21,830 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-11-04 | 2021-11-05 | 23,251 | — | $0 | 23,251 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-11-04 | 2021-11-05 | 2,706 | $112.44 | $304.3K | 38,997 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-11-04 | 2021-11-05 | 6,336 | $111.47 | $706.3K | 41,703 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-11-04 | 2021-11-05 | 5,650 | $113.54 | $641.5K | 33,347 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-11-04 | 2021-11-05 | 2,728 | $114.49 | $312.3K | 30,619 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-11-04 | 2021-11-05 | 7,264 | $115.51 | $839.1K | 23,355 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-11-04 | 2021-11-05 | 23,251 | $29.52 | $686.4K | 53,523 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-11-04 | 2021-11-05 | 5,484 | $110.64 | $606.7K | 48,039 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-11-01 | 2021-11-03 | 12,421 | — | $0 | 12,421 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-11-01 | 2021-11-03 | 12,421 | — | $0 | 35,775 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-11-01 | 2021-11-03 | 5,503 | $118.29 | $650.9K | 30,272 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-09-09 | 2021-09-13 | 23,250 | — | $0 | 46,502 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-09-09 | 2021-09-13 | 496 | $108.26 | $53.7K | 23,354 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-09-09 | 2021-09-13 | 22,754 | $107.83 | $2.45M | 23,850 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-09-09 | 2021-09-13 | 23,250 | $29.52 | $686.3K | 46,604 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-07-28 | 2021-07-30 | 17,418 | — | $0 | 17,418 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award | 2021-07-28 | 2021-07-30 | 8,708 | — | $0 | 27,212 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-07-28 | 2021-07-30 | 3,858 | $102.50 | $395.4K | 23,354 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-02-17 | 2021-02-19 | 4,718 | — | $0 | 4,718 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-02-17 | 2021-02-19 | 17,416 | — | $0 | 17,416 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-02-17 | 2021-02-19 | 1,045 | $87.17 | $91.1K | 17,742 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award | 2021-02-17 | 2021-02-19 | 2,358 | — | $0 | 18,787 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2021-01-05 | 2021-01-06 | 14,513 | — | $0 | 29,028 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-01-05 | 2021-01-06 | 14,513 | — | $0 | 22,955 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-01-05 | 2021-01-06 | 6,526 | $73.28 | $478.2K | 16,429 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-01-04 | 2021-01-06 | 34,928 | — | $0 | 34,928 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-11-01 | 2020-11-03 | 12,420 | — | $0 | 24,842 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2020-11-01 | 2020-11-03 | 5,503 | $74.93 | $412.3K | 8,442 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-11-01 | 2020-11-03 | 12,420 | — | $0 | 13,945 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2020-01-03 | 2020-01-07 | 43,541 | — | $0 | 43,541 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2019-11-01 | 2019-11-05 | 37,262 | — | $0 | 37,262 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2019-11-01 | 2019-11-05 | 69,752 | — | $0 | 69,752 | SEC↗ |